IPC
ABMD

Independent Portfolio Consultants’s Abiomed Inc ABMD Stock Holding History

Independent Portfolio Consultants’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$64K Sell
449
-166
-27% -$22.3K 0.03% 484
2017
Q1 		$77K Buy
+615
New +$71.3K 0.03% 500

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Independent Portfolio Consultants's ABMD Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Abiomed Inc (ABMD) stake by 27% in Q2 2017, selling an estimated $22.3K and leaving 449 shares worth $64K. The position accounts for 0.03% of the portfolio, ranked #484.

Independent Portfolio Consultants first reported a position in ABMD in Q1 2017 and has held it in 2 quarters since. The position peaked at $77K in Q1 2017. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • Independent Portfolio Consultants held 449 shares of Abiomed Inc worth $64K as of Q2 2017.
  • Independent Portfolio Consultants sold 166 Abiomed Inc shares in Q2 2017, an estimated $22.3K.
  • Abiomed Inc made up 0.03% of Independent Portfolio Consultants's portfolio in Q2 2017, its #484 holding.
  • Independent Portfolio Consultants first reported a position in Abiomed Inc in Q1 2017 and has held it in 2 quarters since.
  • Independent Portfolio Consultants's Abiomed Inc position peaked at $77K in Q1 2017.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.